We're Not Very Worried About Veritas In Silico's (TSE:130A) Cash Burn Rate
Apr 14
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedApr 14, 2026
DataAggregated Company Financials
Companies14
- 7D0.4%
- 3M-7.4%
- 1Y6.7%
- YTD-7.0%
The Life Sciences industry is up 2.9% in the last week, with Shin Nippon Biomedical Laboratories up 1.2%. This means that the industry has gained 8.5% over the past year. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 14 Apr 2026 | JP¥142.0b | JP¥63.3b | -JP¥864,496,000.00 | 21.3x | -164.3x | 2.2x |
| Thu, 12 Mar 2026 | JP¥149.0b | JP¥63.2b | -JP¥944,048,000.00 | 22.7x | -157.9x | 2.4x |
| Sat, 07 Feb 2026 | JP¥150.9b | JP¥66.9b | JP¥72.2m | 23.8x | 2091x | 2.3x |
| Mon, 05 Jan 2026 | JP¥151.2b | JP¥66.9b | JP¥72.2m | 21.7x | 2094.5x | 2.3x |
| Wed, 03 Dec 2025 | JP¥168.3b | JP¥67.6b | JP¥747.9m | 17.6x | 225x | 2.5x |
| Fri, 31 Oct 2025 | JP¥131.9b | JP¥66.5b | JP¥1.5b | 15.7x | 90.4x | 2x |
| Sun, 28 Sep 2025 | JP¥149.0b | JP¥66.5b | JP¥1.5b | 17.1x | 102.1x | 2.2x |
| Tue, 26 Aug 2025 | JP¥149.2b | JP¥66.5b | JP¥1.5b | 17.1x | 102.3x | 2.2x |
| Thu, 24 Jul 2025 | JP¥140.5b | JP¥66.0b | JP¥1.1b | 16.4x | 124.4x | 2.1x |
| Sat, 21 Jun 2025 | JP¥139.8b | JP¥66.0b | JP¥1.1b | 16.6x | 123.4x | 2.1x |
| Mon, 19 May 2025 | JP¥135.1b | JP¥65.9b | JP¥1.4b | 15x | 94.7x | 2x |
| Wed, 16 Apr 2025 | JP¥130.0b | JP¥63.8b | JP¥963.0m | 14x | 135x | 2x |
| Fri, 14 Mar 2025 | JP¥161.5b | JP¥64.8b | JP¥927.9m | 15.4x | 174.1x | 2.5x |
| Sun, 09 Feb 2025 | JP¥173.8b | JP¥66.0b | JP¥1.6b | 15.9x | 109.8x | 2.6x |
| Tue, 07 Jan 2025 | JP¥163.5b | JP¥62.0b | JP¥440.7m | 17.2x | 371x | 2.6x |
| Thu, 05 Dec 2024 | JP¥161.0b | JP¥62.0b | JP¥825.9m | 16.6x | 195x | 2.6x |
| Sat, 02 Nov 2024 | JP¥149.8b | JP¥61.5b | JP¥1.8b | 21.2x | 81.3x | 2.4x |
| Mon, 30 Sep 2024 | JP¥157.2b | JP¥61.5b | JP¥1.8b | 18.5x | 85.4x | 2.6x |
| Wed, 28 Aug 2024 | JP¥168.8b | JP¥61.5b | JP¥2.1b | 21x | 80.1x | 2.7x |
| Fri, 26 Jul 2024 | JP¥162.0b | JP¥61.8b | JP¥3.2b | 25.1x | 50.1x | 2.6x |
| Sun, 23 Jun 2024 | JP¥162.9b | JP¥61.8b | JP¥3.2b | 26x | 50.3x | 2.6x |
| Tue, 21 May 2024 | JP¥168.0b | JP¥62.1b | JP¥3.2b | 17.3x | 51.8x | 2.7x |
| Thu, 18 Apr 2024 | JP¥180.6b | JP¥62.3b | JP¥3.3b | 14.2x | 54.9x | 2.9x |
| Sat, 16 Mar 2024 | JP¥227.6b | JP¥155.4b | JP¥8.6b | 13.8x | 26.4x | 1.5x |
| Mon, 12 Feb 2024 | JP¥232.8b | JP¥156.2b | JP¥9.0b | 14.6x | 25.8x | 1.5x |
| Wed, 10 Jan 2024 | JP¥232.6b | JP¥167.1b | JP¥8.5b | 15.6x | 27.4x | 1.4x |
| Fri, 08 Dec 2023 | JP¥231.5b | JP¥167.4b | JP¥8.7b | 15x | 26.7x | 1.4x |
| Sun, 05 Nov 2023 | JP¥225.7b | JP¥179.4b | JP¥12.9b | 14.3x | 17.5x | 1.3x |
| Tue, 03 Oct 2023 | JP¥248.2b | JP¥179.3b | JP¥12.8b | 15.5x | 19.4x | 1.4x |
| Thu, 31 Aug 2023 | JP¥267.8b | JP¥179.3b | JP¥12.8b | 16.8x | 20.9x | 1.5x |
| Sat, 29 Jul 2023 | JP¥268.7b | JP¥178.7b | JP¥15.7b | 16.1x | 17.2x | 1.5x |
| Mon, 26 Jun 2023 | JP¥285.8b | JP¥178.5b | JP¥16.2b | 17.1x | 17.6x | 1.6x |
| Wed, 24 May 2023 | JP¥279.8b | JP¥178.1b | JP¥15.9b | 15.8x | 17.6x | 1.6x |
| Fri, 21 Apr 2023 | JP¥286.0b | JP¥171.9b | JP¥13.3b | 16.5x | 21.5x | 1.7x |
Price to Earnings Ratio
21.5x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 28% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 2.38% | |
| Healthcare | -2.05% | |
| Life Sciences | 0.38% | |
| Clinical Research and Equipment | 0.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.51k | 0.4% +JP¥249.8m | 19.7% | PE15.7x | |
| 4241 atect | JP¥728.00 | 6.7% +JP¥203.4m | 94.7% | PE24.4x | |
| 130A Veritas In Silico | JP¥487.00 | 5.9% +JP¥175.2m | -35.1% | PS34.7x | |
| 4892 Cyfuse Biomedical K.K | JP¥623.00 | 2.5% +JP¥149.5m | -36.6% | PS27x | |
| 4572 Carna Biosciences | JP¥405.00 | 1.8% +JP¥134.3m | 64.6% | PS13.4x |